---
figid: PMC4086757__cmr-24-408-g003
figlink: /pmc/articles/PMC4086757/figure/F1/
number: Fig. 1
caption: Classification of resistance mechanisms to BRAF inhibitors. The figure shows
  a classification system for both de-novo and acquired resistance mechanisms to the
  selective BRAF inhibitors relative to the BRAF mutation. Such resistance mechanisms
  may lie upstream, downstream or at the same level along the mitogen-activated protein
  kinase pathway, or act through a bypass signalling pathway. AKT, protein kinase
  B; BRAF, v-raf murine sarcoma viral oncogene homologue B1; COT, P MAP3K8/mitogen-activated
  protein kinase kinase kinase 8; ERK, extracellular signal-regulated kinase; GCN,
  gene copy number; IGF-1R, insulin-like growth factor 1 receptor; MEK, mitogen-activated
  protein kinase kinase; mTOR, mammalian target of rapamycin; NRAS, neuroblastoma
  RAS viral oncogene homologue; PDGFR-β, platelet-derived growth factor receptor β;
  PI3K, phosphoinositide 3-kinase; PTEN, phosphatase and tensin homologue; RAS, rat
  sarcoma; RTK, receptor tyrosine kinase. Modified from Lemech et al. .
pmcid: PMC4086757
papertitle: Resistance surveillance in a BRAF mutant melanoma patient on long-term
  BRAF-inhibitor treatment.
reftext: Gabriel Mak, et al. Melanoma Res. 2014 Aug;24(4):408-412.
pmc_ranked_result_index: '115397'
pathway_score: 0.8644968
filename: cmr-24-408-g003.jpg
figtitle: Classification of resistance mechanisms to BRAF inhibitors
year: '2014'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4086757__cmr-24-408-g003.html
  '@type': Dataset
  description: Classification of resistance mechanisms to BRAF inhibitors. The figure
    shows a classification system for both de-novo and acquired resistance mechanisms
    to the selective BRAF inhibitors relative to the BRAF mutation. Such resistance
    mechanisms may lie upstream, downstream or at the same level along the mitogen-activated
    protein kinase pathway, or act through a bypass signalling pathway. AKT, protein
    kinase B; BRAF, v-raf murine sarcoma viral oncogene homologue B1; COT, P MAP3K8/mitogen-activated
    protein kinase kinase kinase 8; ERK, extracellular signal-regulated kinase; GCN,
    gene copy number; IGF-1R, insulin-like growth factor 1 receptor; MEK, mitogen-activated
    protein kinase kinase; mTOR, mammalian target of rapamycin; NRAS, neuroblastoma
    RAS viral oncogene homologue; PDGFR-β, platelet-derived growth factor receptor
    β; PI3K, phosphoinositide 3-kinase; PTEN, phosphatase and tensin homologue; RAS,
    rat sarcoma; RTK, receptor tyrosine kinase. Modified from Lemech et al. .
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT1
  - NRAS
  - AKT3
  - PTEN
  - PDGFRB
  - KRAS
  - MAP2K2
  - IGF1R
  - HRAS
  - RAF1
  - MTOR
  - MAPK3
  - CROT
  - AKT2
  - BRAF
  - MAPK1
  - CCND1
  - MAP2K1
  - CDK4
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: PDGFR-B,
  symbol: PDGFRB
  source: hgnc_symbol
  hgnc_symbol: PDGFRB
  entrez: '5159'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: IGF-1R
  symbol: IGF1R
  source: hgnc_symbol
  hgnc_symbol: IGF1R
  entrez: '3480'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: CRAF
  symbol: c-Raf
  source: hgnc_alias_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: NRAS
  symbol: NRAS
  source: hgnc_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: COT
  symbol: COT
  source: hgnc_alias_symbol
  hgnc_symbol: CROT
  entrez: '54677'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: BRAF
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: cyclinD1,CDK4
  symbol: Cyclin-D1
  source: bioentities_symbol
  hgnc_symbol: CCND1
  entrez: '595'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: CDK4
  symbol: CDK4
  source: hgnc_symbol
  hgnc_symbol: CDK4
  entrez: '1019'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
